Literature DB >> 32876843

Assessment of YKL-40, lipid profile, antioxidant status, and some trace elements in benign and malignant breast proliferation.

Eman M Shahy1, Mona M Taha1, Khadiga S Ibrahim2.   

Abstract

Breast cancer is mainly the common form of cancer in women and is a leading cause of death worldwide associated with cancer. The objective of this study was to assess the possible association of lipid profiles (total cholesterol TC, low-density lipoprotein LDL, very-low-density lipoprotein VLDL, high-density lipoprotein HDL, non-HDL and triglyceride TG), Chitinase-3-Like Protein1 (YKL-40) and changes in the levels of certain trace elements (Cu, Mg, Fe, and Zn), antioxidant status (TAC) and nitric oxide (NO) in benign and breast cancer in Egyptian females population. For 56 females with a benign breast tumor, 58 females with breast cancer, besides 52 healthy controls, Serum lipid profile, YKL-40, TAC, NO, Cu, Fe, Zn, and Mg have been determined. Our results showed a significant difference in lipid profile and a significant increase in, YKL-40, NO, and iron in breast benign tumor and cancer patients compared to control one. Besides, there is a significant reduction in serum magnesium and TAC levels in the patients' group compared to the healthy group. There is also a significant correlation between serum YKL-40 level and TC, LDL-C, VLDL-C, non-HDL-C, and TG in the breast cancer group; although only YKL-40 and VLDL-C showed a significant positive correlation in benign tumor patients. It is recommended that non-HDL-cholesterol, TAC, and Mg be used as biomarkers for breast cancer and its progression.

Entities:  

Keywords:  Benign tumor; Breast cancer; Lipid profile; Nitric oxide; Total antioxidant capacity; Trace elements; YKL-40

Mesh:

Substances:

Year:  2020        PMID: 32876843     DOI: 10.1007/s11033-020-05756-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  55 in total

Review 1.  Benign breast disorders.

Authors:  Richard J Santen; Robert Mansel
Journal:  N Engl J Med       Date:  2005-07-21       Impact factor: 91.245

Review 2.  Benign breast diseases: classification, diagnosis, and management.

Authors:  Merih Guray; Aysegul A Sahin
Journal:  Oncologist       Date:  2006-05

3.  The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer.

Authors:  Xing Li; Hailin Tang; Jin Wang; Xinhua Xie; Peng Liu; Yanan Kong; Feng Ye; Zeyu Shuang; Zeming Xie; Xiaoming Xie
Journal:  Breast       Date:  2016-12-08       Impact factor: 4.380

4.  Global cancer statistics, 2012.

Authors:  Lindsey A Torre; Freddie Bray; Rebecca L Siegel; Jacques Ferlay; Joannie Lortet-Tieulent; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2015-02-04       Impact factor: 508.702

5.  Serum lipids and apolipoproteins in women with breast masses.

Authors:  D M Lane; K K Boatman; W J McConathy
Journal:  Breast Cancer Res Treat       Date:  1995-05       Impact factor: 4.872

6.  Serum high-density lipoprotein cholesterol, metabolic profile, and breast cancer risk.

Authors:  Anne-Sofie Furberg; Marit Bragelien Veierød; Tom Wilsgaard; Leslie Bernstein; Inger Thune
Journal:  J Natl Cancer Inst       Date:  2004-08-04       Impact factor: 13.506

Review 7.  Unravelling the role of fatty acid metabolism in cancer through the FOXO3-FOXM1 axis.

Authors:  Paula Saavedra-García; Katie Nichols; Zimam Mahmud; Lavender Yuen-Nam Fan; Eric W-F Lam
Journal:  Mol Cell Endocrinol       Date:  2017-01-11       Impact factor: 4.102

Review 8.  Obesity and cancer progression: is there a role of fatty acid metabolism?

Authors:  Seher Balaban; Lisa S Lee; Mark Schreuder; Andrew J Hoy
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

9.  A Mendelian randomization study of the effects of blood lipids on breast cancer risk.

Authors:  Christoph Nowak; Johan Ärnlöv
Journal:  Nat Commun       Date:  2018-09-27       Impact factor: 14.919

10.  Application of non-HDL cholesterol for population-based cardiovascular risk stratification: results from the Multinational Cardiovascular Risk Consortium.

Authors:  Fabian J Brunner; Christoph Waldeyer; Francisco Ojeda; Veikko Salomaa; Frank Kee; Susana Sans; Barbara Thorand; Simona Giampaoli; Paolo Brambilla; Hugh Tunstall-Pedoe; Marie Moitry; Licia Iacoviello; Giovanni Veronesi; Guido Grassi; Ellisiv B Mathiesen; Stefan Söderberg; Allan Linneberg; Hermann Brenner; Philippe Amouyel; Jean Ferrières; Abdonas Tamosiunas; Yuriy P Nikitin; Wojciech Drygas; Olle Melander; Karl-Heinz Jöckel; David M Leistner; Jonathan E Shaw; Demosthenes B Panagiotakos; Leon A Simons; Maryam Kavousi; Ramachandran S Vasan; Robin P F Dullaart; S Goya Wannamethee; Ulf Risérus; Steven Shea; James A de Lemos; Torbjørn Omland; Kari Kuulasmaa; Ulf Landmesser; Stefan Blankenberg
Journal:  Lancet       Date:  2019-12-03       Impact factor: 79.321

View more
  1 in total

1.  The Inverse Association of Serum Magnesium with Papillary Thyroid Cancer in Thyroid Nodules: a Cross-Sectional Survey Based on Thyroidectomy Population.

Authors:  Huaijin Xu; Xiaodong Hu; Jiefei Li; Zhimei Nie; Shaoyang Kang; Hongzhou Liu; Yuhan Wang; Xiaomeng Jia; Zhaohui Lyu
Journal:  Biol Trace Elem Res       Date:  2022-10-13       Impact factor: 4.081

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.